1. Albright, L., Madigan, J.C., Gaston, M.R., et al.: Therapy in an intracerebral muringe glioma model, using Bacillus Calmette-Guérin, neuraminidase treated tumor cells, and 1-(2-chloroethyl)3-cyclohexyl-1-nitrosourea. Cancer Res. 35, 658?665 (1975)
2. Baker, M., Hoshino, T., Gurcay, O., et al.: Development of an animal brain tumor model and its response to therapy with 1.3-Bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 33, 976?986 (1973)
3. Brisman, R., Housepian, E.M., Chang, C., et al.: Adjuvant introsourea therapy for glioblastoma. Arch. Neurol. 33, 745?750 (1976)
4. Fewer, D., Wilson, C.B., Boldrey, E.B., et al.: Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumor. Cancer Chemother. Rep. 56, 421?427 (1972)
5. Levin, V.A., Shapiro, W.R., Clancy, T.P., et al.: The uptake, distribution and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma. Cancer Res. 30, 2451?2455 (1970)